Top

Published in:

Open Access 01-06-2007 | Original Paper

Drug related problems and off-label drug treatment in children as seen at a drug information centre

Authors: Elin Kimland, Ulf Bergman, Synnöve Lindemalm, Ylva Böttiger

Published in: European Journal of Pediatrics | Issue 6/2007

Abstract

The aim of this work was to analyse the characteristics of Questions and Answers (Q&As) at a drug information centre (DIC) regarding drug related problems and off-label drug treatment in children. All questions concerning children 15 years or younger at a DIC in Stockholm, Sweden during the years 1995–2004 were analysed with respect to the main drug related problem, drug/s and drug group/s, whether the drugs were licensed or not, pediatric labelling of the drug/s and age and sex of the patient. Q&As were classified as whether or not they included evaluated literature information, adding to the labelling of the drugs. We identified 249 Q&As concerning pediatric drug treatment. Each question addressed an average of 1.5 drugs. More than two-thirds of the Q&As concerned adverse drug reactions and pediatric drug choice or dosing. Every second question was classified as off-label, psychotropic drugs being the most common. In half of all off-label Q&As, pediatric documentation on drug efficacy and safety outside the Swedish catalogue of medical products was found. Most Q&As concerned newborns and infants. However, the off-label proportion among questions was highest in adolescence as well as the evaluated literature information, adding to the labelling of the drugs. It was thus found that off-label drug treatment is common among pediatric questions at a DIC. This service can provide additional literature based information contributing to a safer use of drugs in children. There is still, however, a substantial need for clinical documentation of drug use in children.

Addis A, Impicciatore P, Miglio D, Colombo F, Bonati M (1995) Drug use in pregnancy and lactation: the work of a regional drug information centre. Ann Pharmacother 29:632–633PubMed

Alván G, Öhman B, Sjöqvist F (1983) Problem oriented drug information: a clinical pharmacological service. Lancet 2:1410–1412PubMedCrossRef

Bramness GJ, Hausken AM, Sakshaug S, Skurtveit S, Rønning M (2005) Prescription of selective serotonin reuptake inhibitors 1990–2004. Tidsskr Nor Laegeforen 125:2470–2473 [in Norwegian]PubMed

Clavenna A, Bonati M, Rossi E, De Rosa M (2004) Increase in non-evidence based use of antidepressants in children is cause for concern. BMJ 328:711–712PubMedCrossRef

Committee on Safety of Medicines (2006) Use of selective serotonin reuptake inhibitors (SSRIs) in children and adolescents with major depressive disorder (MDD). Medicines and Healthcare products Regulatory Agency (MHRA), UK. Available at: http://www.mhra.gov.uk. Cited 01 March 2006

Conroy S (2002) Unlicensed and off-label drug use. Pediatr Drugs 4:353–359

Easton LK, Colin BC, Brien JE (2004) Frequency and characteristics of hospital admissions associated with drug-related problems in paediatrics. Br J Clin Pharmacol 57:611–615PubMedCrossRef

Ekins-Daukes S, Helms PJ, Taylor MW, McLay JS (2005) Off-label prescribing to children: attitude and experience of general practitioners. Br J Clin Pharmacol 60:145–149PubMedCrossRef

Elwin CE (1981) Trimethoprim- sulphamethoxazole during pregnancy. Experience of a follow-up of a register at a drug information centre. In: Nordbring F, Burman LG (eds) Urinary tract infections: current aspects of pathogenesis, prognosis and trimethoprim-sulphametoxazole therapy: proceeding of a Wellcome foundation symposium held in Stockholm, March 29–30,1979. Almqvist & Wiksell International, Stockholm, pp 109–115

10.

FASS (2004) The Swedish catalogue of medical products, 1995–2004. LIF, Stockholm, Sweden

11.

Impicciatore P, Choonara I (1999) Status of new medicines approved by the European medicines evaluation agency regarding paediatric use. Br J Clin Pharmacol 48:15–18PubMedCrossRef

12.

Impicciatore P, Choonara I, Clarkson A, Provasi A, Pandolfini C, Bonati M (2001) Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol 52:77–83PubMedCrossRef

13.

Jonville-Béra AP, Béra F, Autret-Leca E (2005) Are incorrectly used drugs more frequently involved in adverse drug reactions? A prospective study. Eur J Clin Pharmacol 61:231–236PubMedCrossRef

14.

Kasilo O, Romero M, Bonati M, Tognoni G (1988) Information on drug use in pregnancy from the viewpoint regional drug information centre. Eur J Clin Pharmacol 35:447–453PubMedCrossRef

15.

Lyrvall H, Nordin C, Jonsson E, Alvan G, Ohman B (1993) Potential savings of consulting a drug information centre. Ann Pharmacother 27:1540PubMed

16.

Madsen H, Andersen M, Hallas J (2001) Drug prescribing among Danish children: a population-based study. Eur J Clin Pharmacol 57:159–165PubMedCrossRef

17.

Martin RM, Wilton LV, Mann RD, Steventon P, Hilton SR (1998) General practitioners prescribe SSRIs to children off-label. BMJ 317:204PubMed

18.

Öhman B, Lyrvall H, Törnqvist E, Alván G, Sjöqvist F (1992) Clinical pharmacology and the provision of drug information. Eur J Clin Pharmacol 42:563–568PubMedCrossRef

19.

Öhman B, Lyrvall H, Alván G (1993) Use of Drugline—a question and answer database. Ann Pharmacother 27:278–284PubMed

20.

Pandolfini C, Bonati M (2005) A literature review on off-label drug use in children. Eur J Pediatrics 164:552–558CrossRef

21.

Sanz EJ, Bergman U, Dahlstrom M (1989) Paediatric drug prescribing. A comparison of Tenerife (Canary Islands, Spain) and Sweden. Eur J Clin Pharmacol 37:65–68PubMed

22.

Schwartz S, Stoelben S, Ebert U, Siepmann M, Krappweis J, Kirch W (1999) Regional drug information service. Int J Clin Pharmacol Therap 37:263–268

23.

Serreau R, Le Heuzey MF, Gilbert A, Mouren MC, Jacqz-Aigain E (2004) Unlicensed and off-label use of psychotropics medications in French children: a prospective study. Paediatr Perinatal Drug Ther 6:14–19CrossRef

24.

Straand J, Rokstad K, Heggedal U (1998) Drug prescribing for children in general practice. A report from the More and Romsadal prescription study. Acta Paediatr 87:218–224PubMedCrossRef

25.

Temple ME, Robinson RF, Miller JC, Hayes JR, Nahata MC (2004) Frequency and preventability of adverse drug reactions in paediatric patients. Drug Saf 27:819–829PubMedCrossRef

26.

‘tJong G, van der Linden P, Bakker E, van der Lely N, Eland I, Stricker B, van den Anker J (2002) Unlicensed and off-label drug use in a paediatric ward of a general hospital in the Netherlands. Eur J Clin Pharmacol 58:293–297CrossRef

27.

Ufer M, Rane A, Karlsson Å, Kimland E, Bergman U (2003) Widespread off-label prescribing of topical but not systemic drugs for 350,000 paediatric outpatients in Stockholm. Eur J Clin Pharmacol 58:779–783PubMed

28.

Ufer M, Kimland E, Bergman U (2004) Adverse drug reactions and off-label prescribing for paediatric outpatients a one-year survey of spontaneous reports in Sweden. Pharmacoepidemiol Drug Saf 13:147–152PubMedCrossRef

29.

WHO (2005) Collaborating centre for drug statistics methodology. About the ATC/DDD system [online]. Available at: http://www.whocc.no/atcddd/. Accessed 28 December 2005

30.

Yaffe SJ, Aranda JV (eds) (2005) Neonatal and pediatric pharmacology: therapeutic principles in practice, 3rd edn. WB Saunders, Philadelphia

Title: Drug related problems and off-label drug treatment in children as seen at a drug information centre
Authors: Elin Kimland
Ulf Bergman
Synnöve Lindemalm
Ylva Böttiger
Publication date: 01-06-2007
Publisher: Springer-Verlag
Published in: European Journal of Pediatrics / Issue 6/2007
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI: https://doi.org/10.1007/s00431-006-0385-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Drug related problems and off-label drug treatment in children as seen at a drug information centre

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2007

Huge, alarming congenital hemangioma of the scalp presenting as heart failure and Kasabach-Merritt syndrome: a case report

Role of routine and mass vaccination campaigns in immunization status of adolescents

Risk factors for sensorineural hearing loss in survivors with severe congenital diaphragmatic hernia

Management of blunt tracheal trauma in children: a case series and review of the literature

Interchangeability of a hepatitis A vaccine second dose: Avaxim 80 following a first dose of Vaqta 25 or Havrix 720 in children in Turkey

Analysis of puberty and pubertal growth in healthy boys